logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home

US Stock Market Move | Affirm Holdings (AFRM.US) rose more than 6%, with the stock price reaching its highest level in 52 weeks at one point.

date
23:19 18/11/2024
avatar
GMT Eight
As of the time of writing, the stock has risen by more than 6%, reaching $59.67.
On Monday, Affirm Holdings (AFRM.US) stock price briefly touched a 52-week high, and as of the time of writing, the stock is up over 6% at $59.67. Mizuho raised their price target on the stock from $65 to $69.
Related Articles
HK Bull/Bear Outstanding Qty Ratio(46:54) | October 17
Overnight US stocks | The three major indices fell, while Apple Inc. (AAPL.US) rose against the trend. The Philadelphia Semiconductor Index fell more than 11% this week.
US Stock Market Move | Biotech company City Therapeutics (CTY.US) debuts on the U.S. stock market, rising nearly 24% after the open.
HK Bull/Bear Outstanding Qty Ratio(46:54) | October 17
Overnight US stocks | The three major indices fell, while Apple Inc. (AAPL.US) rose against the trend. The Philadelphia Semiconductor Index fell more than 11% this week.
US Stock Market Move | Biotech company City Therapeutics (CTY.US) debuts on the U.S. stock market, rising nearly 24% after the open.
RECOMMEND
Why ATGL's Small Scale Could Become an Advantage in Enterprise AI
Why ATGL's Small Scale Could Become an Advantage in Enterprise AI
icon
25/09/2026
From IT Services to Enterprise AI: What ATGL Must Prove Next
From IT Services to Enterprise AI: What ATGL Must Prove Next
icon
24/09/2026
Anthony Tsang’s Strategic Control Could Be the Key to ATGL’s AI Transformation
Anthony Tsang’s Strategic Control Could Be the Key to ATGL’s AI Transformation
icon
22/09/2026
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.